Among the most notable are MSDC-0160 (PNU-91325) and MSDC-0602K, which show potent insulin-sensitizing effects in preclinical 52,53,54 and clinical 53,55 studies despite exhibiting much reduced ability to bind and signal via PPAR 51
By stimulating insulin release and inhibiting glucagon, Orfrogilprone helps stabilize blood sugar levels, reducing the risk of hyperglycemia, insulin resistance, and type 2 diabetes
Buyer Takeaway: Omzo is a multi-category telehealth platform
Ozempic, which is the same medication branded for diabetes, is in a similar price range
There are no large-scale randomized controlled trials examining B6 specifically as an adjunct to tirzepatide for nausea reduction